Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions
NCT02231957 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 416
Last updated 2017-01-30
Summary
There are a growing number of adolescents with chronic medical conditions in the United States. The Advisory Committee on Immunization Practices (ACIP) recommends HPV vaccination and annual influenza vaccination of all adolescents. Pneumococcal polysaccharide vaccination is also recommended for certain high-risk patients. Limited studies suggest that vaccination coverage of this population remains sub-optimal. Text message vaccine reminder/recall has been shown to be effective in increasing uptake of select pediatric and adolescents vaccines, but has yet to be examined among patients with chronic medical conditions who may also face unique barriers to vaccination. This intervention aims to implement and evaluate the use of text message vaccine reminders among urban low-income minority adolescents with chronic medical conditions. This investigator-initiated study is supported in part by a grant from the Pfizer Medical Education Group.
Conditions
- Vaccination
Interventions
- OTHER
-
educational text message reminders
- OTHER
-
conventional text message reminders
Sponsors & Collaborators
- collaborator INDUSTRY
- lead OTHER
Principal Investigators
-
Annika M Hofstetter, MD, PhD, MPH · Columbia University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 11 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-07-31
- Primary Completion
- 2015-06-30
- Completion
- 2017-01-31
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients
NCT01057888 ·Status: COMPLETED ·Phase: NA
-
COVID-19 Booster Dose Reminder/Recall for Adolescents
NCT05571657 ·Status: UNKNOWN ·Phase: NA
-
Adolescent Vaccination Kiosk Project
NCT01622608 ·Status: COMPLETED ·Phase: NA
-
Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake
NCT03000998 ·Status: COMPLETED ·Phase: NA
-
4 Pillars Toolkit for Adolescent Vaccination
NCT02165722 ·Status: COMPLETED ·Phase: NA
-
A School Health Center Intervention to Increase Adolescent Vaccination
NCT01595542 ·Status: COMPLETED ·Phase: NA
-
School Located Adolescent Vaccination Study
NCT01719679 ·Status: COMPLETED ·Phase: NA
-
Study of Adolescent Immunization Recall Systems
NCT01390363 ·Status: COMPLETED ·Phase: NA
-
Development and Testing of ADEPT: A Parent Decision Support for Childhood Vaccinations
NCT04496453 ·Status: COMPLETED ·Phase: NA
-
Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age
NCT01346293 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®
NCT00355121 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine
NCT06184542 ·Status: RECRUITING ·Phase: PHASE1
-
Promoting Tolerance to Common Allergens in High-Risk Children: Global Prevention of Asthma in Children (GPAC) Study
NCT00346398 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years
NCT00329901 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 003
NCT01661751 ·Status: COMPLETED ·Phase: PHASE3
-
Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)
NCT00325130 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine
NCT00777257 ·Status: COMPLETED ·Phase: PHASE4
-
US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease
NCT00282295 ·Status: COMPLETED ·Phase: PHASE4
-
Phone Text Message Reminders on Compliance With Human Rabies Post Exposure Prophylaxis Project
NCT05350735 ·Status: COMPLETED ·Phase: NA
-
Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine
NCT00304265 ·Status: COMPLETED ·Phase: PHASE4
-
Parental Views Related to Colorado State Legislation About Vaccinations, Schools, and Child Care Centers
NCT02957344 ·Status: COMPLETED
-
Influence of BCG on TDaP-IPV Vaccination
NCT02771782 ·Status: UNKNOWN ·Phase: PHASE4
-
Vouchers to Promote Tdap Vaccination
NCT01860378 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines
NCT00004799 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Effectiveness and Safety of Tetrabenazine MR in Pediatric Subjects With Tourette's Syndrome
NCT01133353 ·Status: WITHDRAWN ·Phase: PHASE2